This integrated biopharmaceutical company provider has seen a mixed track record when it comes to estimate revisions of 1 increase and 2 decreases in the last 60 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s rally can turn into more strength down the road.
Rockwell Medical currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks worth considering in the medical products industry are ICU Medical, Inc. (ICUI), Abaxis, Inc. (ABAX) and Eagle Pharmaceuticals Inc. (EGRX). While ICU Medical sports a Zacks Rank #1 (Strong Buy), Abaxis and Eagle Pharmaceuticals carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment